J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amir, E
Right arrow Articles by Howell, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amir, E
Right arrow Articles by Howell, A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Breast Cancer
*Genetic Testing
Journal of Medical Genetics 2003;40:807-814
© 2003 BMJ Publishing Group Ltd


ORIGINAL ARTICLE

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

E Amir1,*, D G Evans2,*, A Shenton2,*, F Lalloo2, A Moran3, C Boggis4, M Wilson4, A Howell5

1 University of Manchester, UK
2 Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary’s Hospital, Manchester, UK
3 Centre for Cancer Epidemiology, University of Manchester, UK
4 Department of Radiology, South Manchester University Hospital Trust, Manchester, UK
5 Department of Medical Oncology, Christie Hospital, Manchester, UK

Correspondence to:
Professor D G Evans
Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary’s Hospital, Hathersage Road, Manchester M13 0JH, UK; gareth.evans{at}cmmc.nhs.uk]

Introduction: Accurate individualised breast cancer risk assessment is essential to provide risk–benefit analysis prior to initiating interventions designed to lower breast cancer risk. Several mathematical models for the estimation of individual breast cancer risk have been proposed. However, no single model integrates family history, hormonal factors, and benign breast disease in a comprehensive fashion. A new model by Tyrer and Cuzick has addressed these deficiencies. Therefore, this study has assessed the goodness of fit and discriminatory value of the Tyrer–Cuzick model against established models namely Gail, Claus, and Ford.

Methods: The goodness of fit and discriminatory accuracy of the models was assessed using data from 1933 women attending the Family History Evaluation and Screening Programme, of whom 52 developed cancer. All models were applied to these women over a mean follow up of 5.27 years to estimate risk of breast cancer.

Results: The ratios (95% confidence intervals) of expected to observed numbers of breast cancers were 0.48 (0.37 to 0.64) for Gail, 0.56 (0.43 to 0.75) for Claus, 0.49 (0.37 to 0.65) for Ford, and 0.81 (0.62 to 1.08) for Tyrer–Cuzick. The accuracy of the models for individual cases was evaluated using ROC curves. These showed that the area under the curve was 0.735 for Gail, 0.716 for Claus, 0.737 for Ford, and 0.762 for Tyrer–Cuzick.

Conclusion: The Tyrer–Cuzick model is the most consistently accurate model for prediction of breast cancer. The Gail, Claus, and Ford models all significantly underestimate risk, although the accuracy of the Claus model may be improved by adjustments for other risk factors.


Keywords: assessment; breast cancer; models; risk; validation

Abbreviations: ROC, receiver operating characteristic




This article has been cited by other articles:


Home page
Science Technology Human ValuesHome page
I. Lowy and J. P. Gaudilliere
Localizing the Global: Testing for Hereditary Risks of Breast Cancer
Science Technology Human Values, May 1, 2008; 33(3): 299 - 325.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. M. Domchek and A. Antoniou
Cancer Risk Models: Translating Family History into Clinical Management
Ann Intern Med, October 2, 2007; 147(7): 515 - 517.
[Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. J Santen, N. F Boyd, R. T Chlebowski, S. Cummings, J. Cuzick, M. Dowsett, D. Easton, J. F Forbes, T. Key, S. E Hankinson, et al.
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 169 - 187.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al.
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Decarli, S. Calza, G. Masala, C. Specchia, D. Palli, and M. H. Gail
Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition Cohort
J Natl Cancer Inst, December 6, 2006; 98(23): 1686 - 1693.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. E. Barlow, E. White, R. Ballard-Barbash, P. M. Vacek, L. Titus-Ernstoff, P. A. Carney, J. A. Tice, D. S. M. Buist, B. M. Geller, R. Rosenberg, et al.
Prospective breast cancer risk prediction model for women undergoing screening mammography.
J Natl Cancer Inst, September 6, 2006; 98(17): 1204 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Palomares, J. R.B. Machia, C. D. Lehman, J. R. Daling, and A. McTiernan
Mammographic density correlation with gail model breast cancer risk estimates and component risk factors.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1324 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
K Hemminki and C Eng
Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans
J. Med. Genet., November 1, 2004; 41(11): 801 - 807.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Breast cancer risk prediction models
Mano S Selvan
J Med Genet, 5 May 2004 [Full text]
Re: Breast cancer risk prediction models
D Gareth Evans, et al.
J Med Genet, 5 May 2004 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.